H. KARADENİZ Et Al. , "Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis," CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1169-1176, 2022
KARADENİZ, H. Et Al. 2022. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis. CLINICAL RHEUMATOLOGY , vol.41, no.4 , 1169-1176.
KARADENİZ, H., AVANOĞLU GÜLER, A., KOCA, G., BİLİCİ SALMAN, R., SATIŞ, H., Atas, N., ... Babaoglu, H.(2022). Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis. CLINICAL RHEUMATOLOGY , vol.41, no.4, 1169-1176.
KARADENİZ, HAZAN Et Al. "Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis," CLINICAL RHEUMATOLOGY , vol.41, no.4, 1169-1176, 2022
KARADENİZ, HAZAN Et Al. "Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis." CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1169-1176, 2022
KARADENİZ, H. Et Al. (2022) . "Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis." CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1169-1176.
@article{article, author={HAZAN KARADENİZ Et Al. }, title={Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis}, journal={CLINICAL RHEUMATOLOGY}, year=2022, pages={1169-1176} }